Table 7.11

Unadjusted Patient Survival, Pancreas After Kidney (PAK) Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

		3 Months			1 Year			3 Years			5 Years
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	426	98.4%	0.6%	426	95.3%	1.0%	248	89.5%	1.9%	167	76.6%	3.3%
Level of HLA Mismatch	0	7	100.0%	0.0%	7	100.0%	0.0%	3	100.0%	0.0%	4	25.0%	21.7%
	1	17	100.0%	0.0%	17	100.0%	0.0%	17	82.4%	9.2%	6	33.3%	19.2%
	2	45	100.0%	0.0%	45	97.8%	2.2%	34	88.2%	5.5%	37	89.2%	5.1%
	3	77	100.0%	0.0%	77	98.7%	1.3%	66	89.4%	3.8%	43	81.4%	5.9%
	4	114	98.2%	1.2%	114	93.9%	2.2%	68	92.6%	3.2%	36	77.8%	6.9%
	5	109	98.2%	1.3%	109	94.5%	2.2%	48	87.5%	4.8%	33	69.7%	8.0%
	6	56	96.4%	2.5%	56	92.9%	3.4%	12	91.7%	8.0%	8	75.0%	15.3%
	Unknown	1	0.0%	0.0%	1	0.0%	0.0%	0	-	-	0	-	-

Source: OPTN/SRTR Data as of August 1, 2003.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during 2000-2001 for 3 month and 1 year; 1998-1999 for 3 year; and 1996-1997 for 5 year survival.

Patient survival follows patients from first transplant of this type until death.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on pancreas and kidney-pancreas transplants.

Multi-organ transplants are excluded.